• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson shares rise on rating upgrade

Article

Acuson's long-suffering stock price got a big boost this monthafter an analyst at Morgan Stanley raised his rating of the stockfrom "neutral" to "outperform."The Mountain View, CA, ultrasound vendor's stock leaped 31%the week of Sept.

Acuson's long-suffering stock price got a big boost this monthafter an analyst at Morgan Stanley raised his rating of the stockfrom "neutral" to "outperform."

The Mountain View, CA, ultrasound vendor's stock leaped 31%the week of Sept. 9, from $13.63 on Sept. 8, the day before therating was issued, to $17.88 at the end of the week. It was tradingat around $17.50 last week.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.